Aureus
AExcellent

Illumina, Inc.(ILMN)

A

Financial data as of Dec 31, 2024Stable · Healthcare

FCF Margin16.2%Free Cash Flow / Revenue
Cash Conversion-68.4%Operating CF / Net Income
Free Cash Flow$709.0M
Revenue$4.4B
Net Cash-$1.5BNet debt position
Debt / FCF3.7xElevated debt burden
Current Ratio1.78Adequate short-term liquidity
YoY FCF Growth-8.5%5 of 5 quarters positive

How This Grade Was Calculated

Base grade from FCF margin, adjusted by financial health factors

BaseA
→
+0.5Healthy FCF margin with manageable debt (16.2%, 3.7x)
→
+0.5Highly consistent quarterly FCF
→
FinalA

Analysis Summary

Strengths

  • Strong FCF margin (16.2%)
  • Highly consistent quarterly FCF

Concerns

  • Net debt position ($1.5B)

Financial Breakdown

Key financials compared side by side

Margin Composition

FCF Margin16.2%
Net Margin-28.0%
Operating CF Margin19.1%
CapEx Ratio2.9%

Balance Sheet Health

Debt, liquidity, and leverage snapshot

Net Cash-$1.5BNet debt position
Debt / FCF3.7xElevated debt burden
Current Ratio1.78Strong liquidity
Debt / Equity1.10Moderate leverage

Quarterly FCF Trend

-8.5% YoYStable (-8.5%)

Free cash flow per quarter

Sector Comparison — Healthcare

FCF Margin ranked against sector peers

View all →

Detailed Metrics

Company NameIllumina, Inc.
SectorHealthcare
Free Cash Flow$709.0M
Revenue$4.4B
Net Income-$1.2B
Operating Cash Flow$837.0M
Capital Expenditure$128.0M
FCF Margin16.2%
Cash Conversion Rate-68.4%
Net Margin-28.0%
Total Debt$2.6B
Total Cash$1.1B
Net Cash-$1.5B
Current Ratio1.78
Debt / Equity1.10
Debt / FCF3.7x
YoY FCF Growth-8.5%
Positive Quarters5 of 5
Trend DirectionStable
Report DateDec 31, 2024
GradeA
Data SourceYahoo Finance